MD, Assistant Professor, Department of Transfusion Medicine, JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Puducherry, 605006, India.
MD, Junior Resident, Department of Transfusion Medicine, JIPMER, Puducherry, India.
Immunohematology. 2023 Apr 5;39(1):11-14. doi: 10.21307/immunohematology-2023-003. Print 2023 Apr 1.
Hemolytic disease of the fetus and newborn (HDFN) due to anti-D was severe and fatal before the development of RhD immune prophylaxis. Proper screening and universal administration of Rh immune globulin has decreased the incidence of HDFN to a great extent. Pregnancy, transfusion, and transplantation still increase the chances of other alloantibody formation and the potential for HDFN. Advanced methods for immunohematology investigation allow for the identification of alloantibodies causative for HDFN other than anti-D. Many antibodies have been reported to cause HDFN, but there is scant literature where isolated anti-C is responsible for HDFN. We present here a case of severe HDFN caused by anti-C leading to severe hydrops and death of the neonate despite three intrauterine transfusions and other measures.
抗 D 所致胎儿和新生儿溶血病(HDFN)在 RhD 免疫预防发展之前较为严重且致命。适当的筛查和普遍应用 Rh 免疫球蛋白已在很大程度上降低了 HDFN 的发生率。妊娠、输血和移植仍会增加其他同种异体抗体形成的机会和发生 HDFN 的可能性。免疫血液学检查的先进方法可鉴定除抗-D 以外导致 HDFN 的同种异体抗体。已有许多抗体被报道可导致 HDFN,但鲜有文献报道单独的抗-C 可导致 HDFN。本研究报道了一例严重的 HDFN 由抗-C 引起,尽管进行了三次宫内输血和其他措施,仍导致新生儿严重水肿和死亡。